Table of Contents 1 CAR T-Cell Immunotherapy Market Overview 1.1 Product Overview and Scope of CAR T-Cell Immunotherapy 1.2 Classification of CAR T-Cell Immunotherapy by Types 1.2.1 Global CAR T-Cell Immunotherapy Revenue Comparison by Types (2019-2024) 1.2.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Types in 2018 1.2.3 Monotherapy 1.2.4 Combination Therapy 1.3 Global CAR T-Cell Immunotherapy Market by Application 1.3.1 Global CAR T-Cell Immunotherapy Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Hematologic Malignancies 1.3.3 Solid Malignancies 1.4 Global CAR T-Cell Immunotherapy Market by Regions 1.4.1 Global CAR T-Cell Immunotherapy Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) CAR T-Cell Immunotherapy Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) CAR T-Cell Immunotherapy Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CAR T-Cell Immunotherapy Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) CAR T-Cell Immunotherapy Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CAR T-Cell Immunotherapy Status and Prospect (2014-2024) 1.5 Global Market Size of CAR T-Cell Immunotherapy (2014-2024) 2 Manufacturers Profiles 2.1 AbbVie 2.1.1 Business Overview 2.1.2 CAR T-Cell Immunotherapy Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 AbbVie CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.2 Celgene 2.2.1 Business Overview 2.2.2 CAR T-Cell Immunotherapy Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Celgene CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.3 Kite Pharma 2.3.1 Business Overview 2.3.2 CAR T-Cell Immunotherapy Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Kite Pharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.4 Oxford BioMedica 2.4.1 Business Overview 2.4.2 CAR T-Cell Immunotherapy Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.5 Novartis 2.5.1 Business Overview 2.5.2 CAR T-Cell Immunotherapy Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Novartis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.6 Gilead 2.6.1 Business Overview 2.6.2 CAR T-Cell Immunotherapy Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Gilead CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.7 Pfizer 2.7.1 Business Overview 2.7.2 CAR T-Cell Immunotherapy Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Pfizer CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.8 Cellectis 2.8.1 Business Overview 2.8.2 CAR T-Cell Immunotherapy Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Cellectis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.9 Bellicum 2.9.1 Business Overview 2.9.2 CAR T-Cell Immunotherapy Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Bellicum CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.10 Mustang Bio 2.10.1 Business Overview 2.10.2 CAR T-Cell Immunotherapy Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Mustang Bio CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.11 CARsgen Therapeutics 2.11.1 Business Overview 2.11.2 CAR T-Cell Immunotherapy Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.12 Xyphos 2.12.1 Business Overview 2.12.2 CAR T-Cell Immunotherapy Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Xyphos CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.13 Minerva Biotechnologies 2.13.1 Business Overview 2.13.2 CAR T-Cell Immunotherapy Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.14 Adaptimmune 2.14.1 Business Overview 2.14.2 CAR T-Cell Immunotherapy Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 Adaptimmune CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.15 Ziopharm Oncology 2.15.1 Business Overview 2.15.2 CAR T-Cell Immunotherapy Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.16 Aurora Biopharma 2.16.1 Business Overview 2.16.2 CAR T-Cell Immunotherapy Type and Applications 2.16.2.1 Product A 2.16.2.2 Product B 2.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 2.17 Creative Biolabs 2.17.1 Business Overview 2.17.2 CAR T-Cell Immunotherapy Type and Applications 2.17.2.1 Product A 2.17.2.2 Product B 2.17.3 Creative Biolabs CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) 3 Global CAR T-Cell Immunotherapy Market Competition, by Players 3.1 Global CAR T-Cell Immunotherapy Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 CAR T-Cell Immunotherapy Players Market Share 3.2.2 Top 10 CAR T-Cell Immunotherapy Players Market Share 3.3 Market Competition Trend 4 Global CAR T-Cell Immunotherapy Market Size by Regions 4.1 Global CAR T-Cell Immunotherapy Revenue and Market Share by Regions 4.2 North America CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 4.3 Europe CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 4.5 South America CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 5 North America CAR T-Cell Immunotherapy Revenue by Countries 5.1 North America CAR T-Cell Immunotherapy Revenue by Countries (2014-2019) 5.2 USA CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 5.3 Canada CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 5.4 Mexico CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 6 Europe CAR T-Cell Immunotherapy Revenue by Countries 6.1 Europe CAR T-Cell Immunotherapy Revenue by Countries (2014-2019) 6.2 Germany CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 6.3 UK CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 6.4 France CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 6.5 Russia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 6.6 Italy CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 7 Asia-Pacific CAR T-Cell Immunotherapy Revenue by Countries 7.1 Asia-Pacific CAR T-Cell Immunotherapy Revenue by Countries (2014-2019) 7.2 China CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 7.3 Japan CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 7.4 Korea CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 7.5 India CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 8 South America CAR T-Cell Immunotherapy Revenue by Countries 8.1 South America CAR T-Cell Immunotherapy Revenue by Countries (2014-2019) 8.2 Brazil CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 8.3 Argentina CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 8.4 Colombia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue CAR T-Cell Immunotherapy by Countries 9.1 Middle East and Africa CAR T-Cell Immunotherapy Revenue by Countries (2014-2019) 9.2 Saudi Arabia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 9.3 UAE CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 9.4 Egypt CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 9.5 Nigeria CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 9.6 South Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) 10 Global CAR T-Cell Immunotherapy Market Segment by Type 10.1 Global CAR T-Cell Immunotherapy Revenue and Market Share by Type (2014-2019) 10.2 Global CAR T-Cell Immunotherapy Market Forecast by Type (2019-2024) 10.3 Monotherapy Revenue Growth Rate (2014-2024) 10.4 Combination Therapy Revenue Growth Rate (2014-2024) 11 Global CAR T-Cell Immunotherapy Market Segment by Application 11.1 Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2014-2019) 11.2 CAR T-Cell Immunotherapy Market Forecast by Application (2019-2024) 11.3 Hematologic Malignancies Revenue Growth (2014-2019) 11.4 Solid Malignancies Revenue Growth (2014-2019) 12 Global CAR T-Cell Immunotherapy Market Size Forecast (2019-2024) 12.1 Global CAR T-Cell Immunotherapy Market Size Forecast (2019-2024) 12.2 Global CAR T-Cell Immunotherapy Market Forecast by Regions (2019-2024) 12.3 North America CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024) 12.4 Europe CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024) 12.6 South America CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure CAR T-Cell Immunotherapy Picture Table Product Specifications of CAR T-Cell Immunotherapy Table Global CAR T-Cell Immunotherapy and Revenue (Million USD) Market Split by Product Type Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Types in 2018 Figure Monotherapy Picture Figure Combination Therapy Picture Table Global CAR T-Cell Immunotherapy Revenue (Million USD) by Application (2014-2024) Figure CAR T-Cell Immunotherapy Revenue Market Share by Applications in 2018 Figure Hematologic Malignancies Picture Figure Solid Malignancies Picture Table Global Market CAR T-Cell Immunotherapy Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024) Figure South America CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024) Figure Global CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024) Table AbbVie Basic Information, Manufacturing Base and Competitors Table AbbVie CAR T-Cell Immunotherapy Type and Applications Table AbbVie CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Celgene Basic Information, Manufacturing Base and Competitors Table Celgene CAR T-Cell Immunotherapy Type and Applications Table Celgene CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Kite Pharma Basic Information, Manufacturing Base and Competitors Table Kite Pharma CAR T-Cell Immunotherapy Type and Applications Table Kite Pharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Oxford BioMedica Basic Information, Manufacturing Base and Competitors Table Oxford BioMedica CAR T-Cell Immunotherapy Type and Applications Table Oxford BioMedica CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis CAR T-Cell Immunotherapy Type and Applications Table Novartis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Gilead Basic Information, Manufacturing Base and Competitors Table Gilead CAR T-Cell Immunotherapy Type and Applications Table Gilead CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer CAR T-Cell Immunotherapy Type and Applications Table Pfizer CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Cellectis Basic Information, Manufacturing Base and Competitors Table Cellectis CAR T-Cell Immunotherapy Type and Applications Table Cellectis CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Bellicum Basic Information, Manufacturing Base and Competitors Table Bellicum CAR T-Cell Immunotherapy Type and Applications Table Bellicum CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Mustang Bio Basic Information, Manufacturing Base and Competitors Table Mustang Bio CAR T-Cell Immunotherapy Type and Applications Table Mustang Bio CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table CARsgen Therapeutics Basic Information, Manufacturing Base and Competitors Table CARsgen Therapeutics CAR T-Cell Immunotherapy Type and Applications Table CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Xyphos Basic Information, Manufacturing Base and Competitors Table Xyphos CAR T-Cell Immunotherapy Type and Applications Table Xyphos CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Minerva Biotechnologies Basic Information, Manufacturing Base and Competitors Table Minerva Biotechnologies CAR T-Cell Immunotherapy Type and Applications Table Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Adaptimmune Basic Information, Manufacturing Base and Competitors Table Adaptimmune CAR T-Cell Immunotherapy Type and Applications Table Adaptimmune CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Ziopharm Oncology Basic Information, Manufacturing Base and Competitors Table Ziopharm Oncology CAR T-Cell Immunotherapy Type and Applications Table Ziopharm Oncology CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Aurora Biopharma Basic Information, Manufacturing Base and Competitors Table Aurora Biopharma CAR T-Cell Immunotherapy Type and Applications Table Aurora Biopharma CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Creative Biolabs Basic Information, Manufacturing Base and Competitors Table Creative Biolabs CAR T-Cell Immunotherapy Type and Applications Table Creative Biolabs CAR T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2017-2018) Table Global CAR T-Cell Immunotherapy Revenue (Million USD) by Players (2014-2019) Table Global CAR T-Cell Immunotherapy Revenue Share by Players (2014-2019) Figure Global CAR T-Cell Immunotherapy Revenue Share by Players in 2017 Figure Global CAR T-Cell Immunotherapy Revenue Share by Players in 2018 Figure Global Top 5 Players CAR T-Cell Immunotherapy Revenue Market Share in 2018 Figure Global Top 10 Players CAR T-Cell Immunotherapy Revenue Market Share in 2018 Figure Global CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global CAR T-Cell Immunotherapy Revenue (Million USD) by Regions (2014-2019) Table Global CAR T-Cell Immunotherapy Revenue Market Share by Regions (2014-2019) Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Regions (2014-2019) Figure Global CAR T-Cell Immunotherapy Revenue Market Share by Regions in 2018 Figure North America CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure Europe CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure South America CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Table North America CAR T-Cell Immunotherapy Revenue by Countries (2014-2019) Table North America CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019) Figure North America CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019) Figure North America CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2018 Figure USA CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure Canada CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure Mexico CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Table Europe CAR T-Cell Immunotherapy Revenue (Million USD) by Countries (2014-2019) Figure Europe CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019) Figure Europe CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2018 Figure Germany CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure UK CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure France CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure Russia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure Italy CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Table Asia-Pacific CAR T-Cell Immunotherapy Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2018 Figure China CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure Japan CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure Korea CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure India CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure Southeast Asia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Table South America CAR T-Cell Immunotherapy Revenue by Countries (2014-2019) Table South America CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019) Figure South America CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019) Figure South America CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2018 Figure Brazil CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure Argentina CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure Colombia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Table Middle East and Africa CAR T-Cell Immunotherapy Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Share by Countries in 2018 Figure Saudi Arabia CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure UAE CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure Egypt CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure Nigeria CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Figure South Africa CAR T-Cell Immunotherapy Revenue and Growth Rate (2014-2019) Table Global CAR T-Cell Immunotherapy Revenue (Million USD) by Type (2014-2019) Table Global CAR T-Cell Immunotherapy Revenue Share by Type (2014-2019) Figure Global CAR T-Cell Immunotherapy Revenue Share by Type (2014-2019) Figure Global CAR T-Cell Immunotherapy Revenue Share by Type in 2019 Table Global CAR T-Cell Immunotherapy Revenue Forecast by Type (2019-2024) Figure Global CAR T-Cell Immunotherapy Market Share Forecast by Type (2019-2024) Figure Global Monotherapy Revenue Growth Rate (2014-2019) Figure Global Combination Therapy Revenue Growth Rate (2014-2019) Table Global CAR T-Cell Immunotherapy Revenue by Application (2014-2019) Table Global CAR T-Cell Immunotherapy Revenue Share by Application (2014-2019) Figure Global CAR T-Cell Immunotherapy Revenue Share by Application (2014-2019) Figure Global CAR T-Cell Immunotherapy Revenue Share by Application in 2019 Table Global CAR T-Cell Immunotherapy Revenue Forecast by Application (2019-2024) Figure Global CAR T-Cell Immunotherapy Market Share Forecast by Application (2019-2024) Figure Global Hematologic Malignancies Revenue Growth Rate (2014-2019) Figure Global Solid Malignancies Revenue Growth Rate (2014-2019) Figure Global CAR T-Cell Immunotherapy Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global CAR T-Cell Immunotherapy Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global CAR T-Cell Immunotherapy Revenue Market Share Forecast by Regions (2019-2024) Figure North America CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024) Figure Europe CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024) Figure Asia-Pacific CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024) Figure South America CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024) Figure Middle East and Africa CAR T-Cell Immunotherapy Revenue Market Forecast (2019-2024)

AbbVie Celgene Kite Pharma Oxford BioMedica Novartis Gilead Pfizer Cellectis Bellicum Mustang Bio CARsgen Therapeutics Xyphos Minerva Biotechnologies Adaptimmune Ziopharm Oncology Aurora Biopharma Creative Biolabs